Dying of a brain tumor, Frederik van den Broek had one last wish on his “bucket list”: serving as his own guinea pig to build a smartphone app for fellow cancer patients.
Now Dutch neurologists say the input from Van den Broek, who died late last month aged 41, has been invaluable in creating what is believed will be the world’s most advanced mobile-based app for cancer patients.
MindApp for Android and iPhone mobiles will allow users with a few simple clicks to track and update appointments, such as for radio and chemo therapy, to help remember who their doctors are and even to manage the myriad pills they must take.
Photo: AFP
It will also allow patients to input data — such as when they have had an epileptic seizure — and “talk” to doctors about their condition without having to come into hospital.
Van den Broek said a few days before his death that his idea for a specialized “brain cancer app” was “born out of pure frustration.”
“The hospital gave me a printout of appointments, which medicines to take, and when, as well as a diagnosis of how long I had to live,” Van den Broek said in an e-mailed interview, his last.
Photo: AFP
“I lost the printout within an hour. These things happen when you’ve lost a large part of your brain and your short-term memory has gone to pieces,” he said.
Van den Broek was intensively involved in the app’s development, with himself as the guinea pig: deciding the features it should have and even the colors to be used to give patients maximum ease of use.
“Brain tumor patients often suffer from loss of cognitive abilities, for instance memory loss and changes in behavior,” said Jaap Reijneveld, a neurologist at Amsterdam’s Free University Medical Centre (VUMC), who is helping with the app’s development.
“This app will be of huge support to patients, particularly those suffering from glioblastoma, a type of brain cancer that’s often highly malignant,” Reijneveld of the VUMC’s brain tumor center said.
“Patients have a massively complicated treatment schedule, and the app, the most advanced to date, will help them remember things, but more importantly, give constant feedback to us as doctors on the patient’s condition,” he said.
The app complements a growing worldwide trend in which new digital technology allows patients to manage their diseases from home, easing the burden on overstretched healthcare facilities.
Easy to set up, MindApp has four sections that can be accessed by a simple touch on a smartphone screen. An appointment calendar is updated automatically once confirmed with the hospital; second, an alarm reminds the patient to take his or her medicines and is turned off once a pill has been taken.
Third, the app features a daily logbook in which patients can make notes of their condition and record episodes, such as epileptic seizures. The information is updated in the patient’s file which doctors are able to access.
The fourth section provides feedback from doctors based on logbook input, for instance instructions to increase or lower the dosage of medications.
Vincent van Dijk, who collaborated with the terminally ill Van den Broek on MindApp’s design until the day he died, said he hoped the first version would be available from “app stores” within the next three months.
Van Dijk said the project is financed through crowd funding and about about 70,000 euros (US$80,000) was needed to finalize MindApp’s development.
Donations so far have totaled about 60,000 euros, and IT giant Microsoft has also offered to help with development, Van Dijk said.
Sadly for Van den Broek, it is too late to benefit from the fruit of his labors.
“It’s a pity I won’t be able to use the app, but it gives me the feeling that at least my illness wasn’t for nothing,” he said.
“Some people go on a world cruise or make a ‘bucket list’ when they hear they’re going to die,” he said. “The MindApp is my bucket list.”
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the
GLOBAL ECONOMY: Policymakers have a choice of a small 25 basis-point cut or a bold cut of 50 basis points, which would help the labor market, but might reignite inflation The US Federal Reserve is gearing up to announce its first interest rate cut in more than four years on Wednesday, with policymakers expected to debate how big a move to make less than two months before the US presidential election. Senior officials at the US central bank including Fed Chairman Jerome Powell have in recent weeks indicated that a rate cut is coming this month, as inflation eases toward the bank’s long-term target of two percent, and the labor market continues to cool. The Fed, which has a dual mandate from the US Congress to act independently to ensure